Drug Database
Back to search

Belgium· BE-AMP-SAM256934-00

Moxonidine EG 0,3 mg

A moxonidine product containing moxonidine, registered in Belgium by EG. The same ATC class is registered in 13 of our 19 countries.

ATC C02AC05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMoxonidine EG 0,3 mgATCC02AC05REGISTER NO.BE-AMP-SAM256934-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about moxonidineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Moxonidine is registered in 13 of 19 countries.

Countries holding a registration under ATC C02AC05 (moxonidine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search moxonidine products by name

Moxonidine · ATC C02AC05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxonidine costs, country by country.

Normalised to the WHO defined daily dose (0.3 mg), the median price runs from $0.19 in France to $0.70 in Switzerland — a ×3.7 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Moxonidine · price per daily dose (0.3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.70
  • IT Italy$0.35
  • FR France$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Moxonidine
Manufacturer
EG
Country
Belgium (BE)
ATC code
C02AC05
ATC class
Moxonidine
Defined daily dose
0.3 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Moxonidine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All moxonidine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Moxonibene, Moxonidin Stada
  • Bulgaria · Moxotens, Moксотенс
  • Cyprus · Physiotens, Tarwoxin
  • Czechia · Cynt, Moxonidin Actavis
  • Germany · Moxogamma, Moxonidin 1 A Pharma
  • Denmark · Moxonat, Moxonidin Teva
  • Estonia · Moxogamma, Moxonidin Actavis
  • Spain · Moxon
  • Finland · Moxonidin Ratiopharm, Moxonidin Stada
  • France · Moxonidine Biogaran, Moxonidine Eg
  • United Kingdom (Northern Ireland) · Moxonidine, Moxonidine Generics [uk]
  • Greece · Cynt, Fisiotens
  • Croatia · Cynt, Moksonidin Belupo
  • Hungary · Moxogamma, Moxonidin Ratiopharm
  • Italy · Fisiotens, Moxonidina Eg
  • Lithuania · Moxogamma, Moxonidin Hexal
  • Luxembourg · Moxonidine Eg, Moxonidine Viatris
  • Latvia · Moxogamma, Moxonidin Actavis
  • Malta · Physiotens
  • Netherlands · Moxamar, Moxonidine Pch
  • Norway · Moxonidin Actavis, Physiotens
  • Poland · Physiotens
  • Portugal · Moxon
  • Romania · Physiotens
  • Sweden · Moxonidin Actavis, Moxonidin Stada
  • Slovenia · Filmsko Obložene Tablete, Moxogamma, Moxogamma
  • Slovakia · Moxogamma, Moxonidin Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5eca95b4-32e6-4e0d-952a-475b9aed1dd0
GET /v1/drugs/5eca95b4-32e6-4e0d-952a-475b9aed1dd0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Moxonidine EG 0,3 mg",
  "name_fr": "Moxonidine EG 0,3 mg",
  "name_nl": "Moxonidine EG 0,3 mg",
  "amp_code": "SAM256934-00",
  "strengths": [
    "0.3000"
  ],
  "pack_count": 9,
  "substances": [
    "Moxonidine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Moxonidine",
  "authorisation_numbers": [
    "BE256934"
  ]
}
API referenceMCP serverPlans

See everything about moxonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console